250 related articles for article (PubMed ID: 24373575)
1. Mucus removal is impaired in children with cystic fibrosis who have been infected by Pseudomonas aeruginosa.
Laube BL; Sharpless G; Benson J; Carson KA; Mogayzel PJ
J Pediatr; 2014 Apr; 164(4):839-45. PubMed ID: 24373575
[TBL] [Abstract][Full Text] [Related]
2. Changes in mucociliary clearance over time in children with cystic fibrosis.
Laube BL; Carson KA; Evans CM; Richardson VL; Sharpless G; Zeitlin PL; Mogayzel PJ
Pediatr Pulmonol; 2020 Sep; 55(9):2307-2314. PubMed ID: 32427408
[TBL] [Abstract][Full Text] [Related]
3. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis.
Aurora P; Bush A; Gustafsson P; Oliver C; Wallis C; Price J; Stroobant J; Carr S; Stocks J;
Am J Respir Crit Care Med; 2005 Feb; 171(3):249-56. PubMed ID: 15516530
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis.
Judge EP; Dodd JD; Masterson JB; Gallagher CG
Chest; 2006 Nov; 130(5):1424-32. PubMed ID: 17099020
[TBL] [Abstract][Full Text] [Related]
5. Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.
Dassios TG; Katelari A; Doudounakis S; Dimitriou G
Respir Care; 2014 Mar; 59(3):363-70. PubMed ID: 23983273
[TBL] [Abstract][Full Text] [Related]
6. Bronchiectases at early chest computed tomography in children with cystic fibrosis are associated with increased risk of subsequent pulmonary exacerbations and chronic pseudomonas infection.
Bortoluzzi CF; Volpi S; D'Orazio C; Tiddens HA; Loeve M; Tridello G; Assael BM
J Cyst Fibros; 2014 Sep; 13(5):564-71. PubMed ID: 24726420
[TBL] [Abstract][Full Text] [Related]
7. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.
Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT
Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593
[TBL] [Abstract][Full Text] [Related]
8. Spirometer-triggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis.
Robinson TE; Leung AN; Northway WH; Blankenberg FG; Bloch DA; Oehlert JW; Al-Dabbagh H; Hubli S; Moss RB
J Pediatr; 2001 Apr; 138(4):553-9. PubMed ID: 11295720
[TBL] [Abstract][Full Text] [Related]
9. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.
Gustafsson PM; De Jong PA; Tiddens HA; Lindblad A
Thorax; 2008 Feb; 63(2):129-34. PubMed ID: 17675316
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosis.
Ren CL; Rosenfeld M; Mayer OH; Davis SD; Kloster M; Castile RG; Hiatt PW; Hart M; Johnson R; Jones P; Brumback LC; Kerby GS
Pediatr Pulmonol; 2012 Jun; 47(6):574-81. PubMed ID: 22081584
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.
Nixon GM; Armstrong DS; Carzino R; Carlin JB; Olinsky A; Robertson CF; Grimwood K
J Pediatr; 2001 May; 138(5):699-704. PubMed ID: 11343046
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
[TBL] [Abstract][Full Text] [Related]
13. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
[TBL] [Abstract][Full Text] [Related]
14. Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index.
Belessis Y; Dixon B; Hawkins G; Pereira J; Peat J; MacDonald R; Field P; Numa A; Morton J; Lui K; Jaffe A
Am J Respir Crit Care Med; 2012 Apr; 185(8):862-73. PubMed ID: 22323305
[TBL] [Abstract][Full Text] [Related]
15. The impact of reflux burden on Pseudomonas positivity in children with cystic fibrosis.
Palm K; Sawicki G; Rosen R
Pediatr Pulmonol; 2012 Jun; 47(6):582-7. PubMed ID: 22162484
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
Kerem E; Viviani L; Zolin A; MacNeill S; Hatziagorou E; Ellemunter H; Drevinek P; Gulmans V; Krivec U; Olesen H;
Eur Respir J; 2014 Jan; 43(1):125-33. PubMed ID: 23598952
[TBL] [Abstract][Full Text] [Related]
17. Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Assael BM
Expert Rev Anti Infect Ther; 2011 Nov; 9(11):967-73. PubMed ID: 22029514
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung.
Locke LW; Myerburg MM; Weiner DJ; Markovetz MR; Parker RS; Muthukrishnan A; Weber L; Czachowski MR; Lacy RT; Pilewski JM; Corcoran TE
Eur Respir J; 2016 May; 47(5):1392-401. PubMed ID: 27009167
[TBL] [Abstract][Full Text] [Related]
19. Change in lung clearance index with microbiological status in children with cystic fibrosis.
Walicka-Serzysko K; Postek M; Milczewska J; Sands D
Pediatr Pulmonol; 2019 Jun; 54(6):729-736. PubMed ID: 30838817
[TBL] [Abstract][Full Text] [Related]
20. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
